ANSAR Medical Technologies, Inc.
Autonomic Nervous System Testing
ANSAR is the innovator of noninvasive real-time digital autonomic nervous system monitoring.
An MIT concept, which ANSAR has developed and patented, establishes the constants for our cardio-respiratory methodology – the frequency method using spectral analysis, the only monitoring method to quantify both branches (sympathetic and parasympathetic), of the autonomic nervous system.
ANSAR is committed to excellence in patient care and to improving the safety, efficiency, and cost-effectiveness of health care technology. ANSAR's patented ANX 3.0 Autonomic Nervous System monitoring technology:
- Measures both branches of the Autonomic Nervous System independently and simultaneously, in real-time. The ANS is comprised of the Parasympathetic and Sympathetic nervous systems.
- Is reimbursable under accepted CPT codes for Autonomic Nervous System testing.
- Has FDA 510(k) Market Clearance.
Have you seen our ad in the journal or publication that serves your specialty? Are you interested in learning more about CAN (Cardiovascular Autonomic Neuropathy) and how Ansar's technology can detect autonomic degradation which can lead to PAN, DAN, and ultimately CAN? For more information please click here.